Skip to main content
OpenTrials
Completed

NCT Number: NCT01429857

Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure

The purpose of this study is to investigate the prognostic value of admission high-sensitivity troponin in patients with acute decompensated heart failure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–89 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Innere Medizin III - Kardiologie, Angiologie und Internistische Intensivtherapie

Homburg, Saarland, 66421, Germany

About this study

Patients admitted for acute decompensated heart failure are included in the study. After gaining informed consent, concentrations of high-sensitivity troponin on admission and on discharge are assessed. 6 months after discharged, the incidence of clinical endpoint (mortality of all cause and of cardiovascular cause, hospitalization) is assessed by telephone contact to the patient and/or the physician. The aim of the study is to investigate the prognostic value of high-sensitivity troponin concentration for predicting death and re-hospitalization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospital admission for acute cardiac decompensation
  • Systolic and / or diastolic heart failure

Exclusion criteria

  • Myocardial infarction in the last 4 weeks
  • Serum creatinine >2.5 mg/dl
  • Pulmonary embolism

Treatment and study plan

Primary outcomes

  1. Time to cardiovascular death or hospitalization

    Time frame: 6 Months Follow-Up

Secondary outcomes

  1. Time to all cause death or hospitalization

    Time frame: 6 Months Follow-Up

Sponsors and collaborators

Lead sponsor

University Hospital, Saarland

Other

Registry information

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Sep 7, 2011
Registry last updated
Jun 14, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.